These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1399933)

  • 21. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
    Miyazakin S; Yamaguchi K
    Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure of polymyxin B to restore sensitivity to quinolones for Pseudomonas aeruginosa.
    Walterspiel JN
    South Med J; 1989 May; 82(5):672. PubMed ID: 2541510
    [No Abstract]   [Full Text] [Related]  

  • 23. Post-antibiotic effect of quinolones on Pseudomonas aeruginosa.
    Sood P; Mandal A; Mishra B
    J Antimicrob Chemother; 1999 Mar; 43(3):425-7. PubMed ID: 10223604
    [No Abstract]   [Full Text] [Related]  

  • 24. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
    Aubert G; Pozzetto B; Dorche G
    J Antimicrob Chemother; 1992 Mar; 29(3):307-12. PubMed ID: 1317371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of various antibiotic combinations using the E-Test method in multiresistant Pseudomonas aeruginosa strains.
    Kocazeybek B; Arabaci U; Erentürk S; Akdur H
    Chemotherapy; 2002 Mar; 48(1):31-5. PubMed ID: 11901254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinolone antimicrobial agents.
    Neu HC
    Annu Rev Med; 1992; 43():465-86. PubMed ID: 1580602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between disc potency and zone size in temafloxacin activity in vitro.
    Reggio S; Bassanetti I; Ceralli M; Giardini R; Sansonetti G
    Drugs Exp Clin Res; 1990; 16(12):611-4. PubMed ID: 2130003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of resistance to quinolone antimicrobials.
    Smith J
    Chemioterapia; 1987 Jun; 6(2 Suppl):208-9. PubMed ID: 3334558
    [No Abstract]   [Full Text] [Related]  

  • 29. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
    Kugelberg E; Löfmark S; Wretlind B; Andersson DI
    J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
    Koikeda S; Okabe H; Shibata H; Hase T; Nakanishi N; Okezaki E; Kato H; Masamune Y
    Jpn J Antibiot; 1989 Jan; 42(1):193-9. PubMed ID: 2468799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of antimicrobial susceptibilities of strains clinically isolated at 8 institutions in Hiroshima City to major oral antimicrobial drugs, mainly new quinolone drugs. Hiroshima Levofloxacin Susceptibility Surveillance Group].
    Fujiue Y; Kuwabara M; Muroki K; Kohara T; Itaha H; Yamasaki M; Sasaki M; Onimura K; Shigemitsu M; Kashiyama S
    Jpn J Antibiot; 2000 Jun; 53(6):409-21. PubMed ID: 10955237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of quinolone resistance genes in a clinical isolate of quinolone-resistant MRSA.
    Kojima T; Yamagishi J; Oyamada Y; Yoshida H; Hattori H; Inoue M; Nakamura S
    Drugs; 1995; 49 Suppl 2():182-4. PubMed ID: 8549296
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibiotic resistant Pseudomonas aeruginosa].
    Gotoh N
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():196-201. PubMed ID: 12717971
    [No Abstract]   [Full Text] [Related]  

  • 34. Bacterial resistance to the quinolone antimicrobial agents.
    Hooper DC; Wolfson JS
    Am J Med; 1989 Dec; 87(6C):17S-23S. PubMed ID: 2690616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance development to fluoroquinolones in Europe.
    Wiedemann B; Zühlsdorf MT
    Am J Med; 1989 Nov; 87(5A):9S-11S. PubMed ID: 2589394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in vitro activities of newer quinolones against Pseudomonas species and Xanthomonas maltophilia isolated from patients with cancer.
    Rolston KV; Messer M; Ho DH
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1812-3. PubMed ID: 2285297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinolone resistance in salmonella: clinical experience.
    Piddock LJ; Whale K; Wise R
    Lancet; 1990 Jun; 335(8703):1459. PubMed ID: 1972228
    [No Abstract]   [Full Text] [Related]  

  • 38. [Microbial studies with a new chemotherapeutic agent penoctonium bromide (Ug 767)].
    Paetzold OH; Neumann J
    Hautarzt; 1969 Feb; 20(2):63-7. PubMed ID: 4982631
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of subinhibitory concentrations of quinolone and macrolide antibiotics on production of thermolabile hemolysins in Pseudomonas aeruginosa].
    Hybenová D; Majtán V
    Epidemiol Mikrobiol Imunol; 1995 Dec; 44(4):169-70. PubMed ID: 8556245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National Antimicrobial Resistance Surveillance, Thailand (NARST) data among clinical isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005.
    Dejsirilert S; Suankratay C; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N; Tantisiriwat W
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S68-75. PubMed ID: 21298847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.